Metal-Free Breakthrough Case Report 4
METAL-FREE™ is not intended as a treatment for any medical or mental health conditions, nor should its use to support functioning in patients that may have medical conditions be understood as a claim that METAL-FREE treats those conditions or that BodyHealth.com endorses the use of METAL-FREE to treat medical conditions. Patients who may have medical conditions should consult a physician and ensure proper diagnosis and treatment.
SUBJECT: Continuation Study of Heavy Metal Detoxification with 61-year-old man
Here is an example where pre-treatment levels show elevations in Antimony, Cadmium and Nickel on June 20, 2001. Following two months of METAL-FREE treatment another provocative stool sample done on August 13, 2001 shows all heavy metals now in normal range.
Here are the results:
CLICK TO VIEW FULL SIZE
Read the rest of the Metal-Free Case Studies:
These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.
Leave a comment
Comments will be approved before showing up.
Also in BodyHealth
When a person has high levels of heavy metals in their bodies, it can drastically damage the immune system and organs, leading to often debilitating health problems. So it stands to reason that preventing heavy metal toxicity in your system is of paramount importance because, if we don’t, it can lead to chronic fatigue, memory loss, hypothyroidism, insomnia, unexplained tremors, depression.... Read More
Flavonoids — sounds like something from science fiction, like androids — but these naturally occurring plant chemicals benefit our bodies and overall health in many ways. When we get enough of them through our diet and supplementation, they can assist with weight management, inflammation relief and muscle recovery, and combat cardiovascular disease by preventing unwanted platelet aggregation. Read More
On average 1 person in the United States dies from a blood clot every 6 minutes, which adds up to about 274 people per day.
Not surprisingly, the pharmaceutical industry has taken notice and the global market for anticoagulant drugs now exceeds 18.9 billion dollars, largely dominated by just a few stand-out drugs like Warfarin (aka Coumadin), Rivaroxaban (Xarelto), and Apixaban (Eliquis).